To the central content area :::

TPEx

Listed Companies

ECO-Fin
:::
:::Listed Companies > Listed Companies Info. > Emerging Stock Board Companies > Listed Company Profile

ESM Companies

For foreign Emerging Stock Board enterprises, ”*- country of incorporation” indicates stocks without par value or with par value other than NT$10, and ”- country of incorporation” indicates stocks with par value of NT$10 per share.
7575 Amed
中文
Basic information
Chairman President Spokesperson Telephone Address ESM Registration Date
WANG, YAO CHIEN WANG, YAO CHIEN CHEN, CHIH-HSIANG 02-22981755 No.14-1 Wuquan 7th Rd.Wugu Dist, New Taipei City 24890, Taiwan 2022/06/24
Industry
category
Key businesses
Biotechnology and Medical Care AMED Biomedical focus on the research and development of UV-Cross-linked Hydrogel, and is a professional R&D and manufacturing company for wound dressing launched in the market under the product brand of “HeraDerm”. The HeraDerm wound care dressing product collection was developed using the unique UV hydrogel, featuring advantages including high absorbent capacity, high biocompatibility and usage convenience, and is suitable for wound care after surgery, as well as wound care applications such as bedsores, diabetic feet and venous ulceration as a result of old age. The HeraDerm collection is currently being purchased and used by 19 medical centers in Taiwan, and will continue to strive for improvement in the future to produce more quality products.
 
Market info
Latest trading info Historic trading info
 
Financial data
Cash flows statement Item
Amount(NTD, in thousands)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Consolidated/Individual
balance sheet
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
Consolidated/Individual
profit and loss
statement
Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Profit
Other comprehensive income
Comprehensive income
Basic earnings per share
 Auditor's report on latest financial statements: auditor's report:
 Investors may find more detailed information on the company by visiting the Market Observation Post System.。
 The information disclosed here concerning foreign enterprises consists of amounts provided in consolidated financial statements.